New blood test could replace invasive cancer biopsies

NCT ID NCT04490564

Completed Knowledge-focused Sponsor: Pharmassist Ltd Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new blood test (liquid biopsy) to find cancer markers in 135 people with head and neck, lung, or skin cancer. The goal was to see if the blood test works as well as a standard tissue biopsy. The study did not provide treatment but aimed to improve how doctors monitor cancer.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

head and neck squamous cell carcinoma melanoma metastatic melanoma non-small cell lung carcinoma Squamous Cell Carcinoma of Head and Neck

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEAD AND NECK SQUAMOUS CELL CARCINOMA MELANOMA NON-SMALL CELL LUNG CANCER

Contacts and locations

Locations

Aretaieio University Hospital of Athens

Athens, Attica, 11528, Greece
Bioclinic

Thessaloniki, Thessaloniki, 546 22, Greece
Metropolital Hospital

Piraeus, Piraeus, 18547, Greece
Sotiria Thoracic Diseases Hospital of Athens

Athens, Attica, 11527, Greece
University General Hospital of Alexandroupoli

Alexandroupoli, Alexandroupolis, 68100, Greece
University General Hospital of Athens Attikon

Athens, Attica, 124 62, Greece

More trials for these conditions

Other studies related to the condition(s) this trial covers.